HYFTOR

Serial Number 88600269
Registration 6907452
700

Registration Progress

Application Filed
Aug 30, 2019
Under Examination
Dec 28, 2021
Approved for Publication
Nov 2, 2021
Published for Opposition
Nov 2, 2021
Registered
Nov 22, 2022

Trademark Image

HYFTOR

Basic Information

Serial Number
88600269
Registration Number
6907452
Filing Date
August 30, 2019
Registration Date
November 22, 2022
Published for Opposition
November 2, 2021
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 22, 2022
Registration
Registered
Classes
005

Rights Holder

Nobelpharma Co., Ltd.

99
Address
NMF Kayabacho Bldg., 1-17-24,
Shinkawa, Chuo-ku
Tokyo 104-0033
JP

Ownership History

Nobelpharma Co., Ltd.

Original Applicant
99
Tokyo JP

Nobelpharma Co., Ltd.

Owner at Publication
99
Tokyo JP

Nobelpharma Co., Ltd.

Original Registrant
99
Tokyo JP

Legal Representation

Attorney
Sandra Epp Ryan

USPTO Deadlines

Next Deadline
1124 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-11-22)
Due Date
November 22, 2028
Grace Period Ends
May 22, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

42 events
Date Code Type Description Documents
Nov 22, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 22, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Oct 20, 2022 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 19, 2022 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 19, 2022 ALIE A ASSIGNED TO LIE Loading...
Sep 16, 2022 ALIE A ASSIGNED TO LIE Loading...
Sep 14, 2022 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 12, 2022 IUAF S USE AMENDMENT FILED Loading...
Sep 12, 2022 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Aug 10, 2022 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Jul 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 12, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jul 12, 2022 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 28, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 28, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 28, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 2, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 2, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 13, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 27, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 27, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 27, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 20, 2021 ALIE A ASSIGNED TO LIE Loading...
Sep 15, 2021 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Jun 14, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 15, 2021 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Loading...
Mar 15, 2021 GNSI S INQUIRY TO SUSPENSION E-MAILED Loading...
Mar 15, 2021 CNSI R SUSPENSION INQUIRY WRITTEN Loading...
Mar 9, 2021 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Aug 21, 2020 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 21, 2020 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 21, 2020 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jun 15, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 15, 2020 ALIE A ASSIGNED TO LIE Loading...
Jun 15, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 4, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 5, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 5, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 5, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 3, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 3, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for skin care; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for the treatment of skin disorders associated with Tuberous sclerosis
First Use Anywhere: Aug 17, 2022
First Use in Commerce: Aug 17, 2022

Classification

International Classes
005